Tumor Mutational Burden (TMB) refers to the total number of mutations per megabase of DNA in a tumor. It serves as a quantitative measure of the mutational load within a cancerous tissue. TMB has gained significant attention as a potential biomarker for predicting the response to immunotherapy, particularly immune checkpoint inhibitors.
